Cerebral cavernous malformation: from mechanism to therapy

DA Snellings, CC Hong, AA Ren… - Circulation …, 2021 - Am Heart Assoc
Cerebral cavernous malformations are acquired vascular anomalies that constitute a
common cause of central nervous system hemorrhage and stroke. The past 2 decades have …

[HTML][HTML] Factor v Leiden thrombophilia

JL Kujovich - Genetics in medicine, 2011 - Elsevier
Factor V Leiden is a genetic disorder characterized by a poor anticoagulant response to
activated Protein C and an increased risk for venous thromboembolism. Deep venous …

American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing

S Middeldorp, R Nieuwlaat… - Blood …, 2023 - ashpublications.org
Background Hereditary and acquired thrombophilia are risk factors for venous
thromboembolism (VTE). Whether testing helps guide management decisions is …

[HTML][HTML] Extracellular histones increase plasma thrombin generation by impairing thrombomodulin‐dependent protein C activation

CT Ammollo, F Semeraro, J Xu, NL Esmon… - Journal of Thrombosis …, 2011 - Elsevier
See also Borissoff JI, ten Cate H. From neutrophil extracellular traps release to thrombosis:
an overshooting host‐defense mechanism? This issue, pp 1791–4. Summary Background …

Elevated factor VIII levels and risk of venous thrombosis

PV Jenkins, O Rawley, OP Smith… - British journal of …, 2012 - Wiley Online Library
Modern thrombophilia testing fails to identify any underlying prothrombotic tendency in a
significant number of patients presenting with objectively confirmed venous …

Coagulation cascade and therapeutics update: relevance to nephrology. Part 1: overview of coagulation, thrombophilias and history of anticoagulants

RLC Adams, RJ Bird - Nephrology, 2009 - Wiley Online Library
Coagulation involves the regulated sequence of proteolytic activation of a series of
zymogens to achieve appropriate and timely haemostasis in an injured vessel, in an …

Thrombophilia, risk factors and prevention

E Campello, L Spiezia, A Adamo… - Expert review of …, 2019 - Taylor & Francis
Introduction: Fifty-three years after the first description of an inherited prothrombotic
condition (antithrombin deficiency), our knowledge on hereditary and acquired causes of …

[HTML][HTML] Autoimmune diseases and venous thromboembolism: a review of the literature

B Zöller, X Li, J Sundquist… - American journal of …, 2012 - ncbi.nlm.nih.gov
Venous thromboembolism (VTE) is major health problem and is sometimes complicated by
lethal pulmonary embolism (PE). Disturbances of the coagulation and anticoagulation …

Antidiabetic and haematological effect of aqueous extract of stem bark of Afzelia africana (Smith) on streptozotocin–induced diabetic Wistar rats

SO Oyedemi, EA Adewusi, OA Aiyegoro… - Asian Pacific journal of …, 2011 - Elsevier
Objective To investigate the antidiabetic properties of aqueous extract of stem bark of Afzelia
africana (A. africana) and its beneficial effect on haematological parameters in …

Protein C anticoagulant and cytoprotective pathways

JH Griffin, BV Zlokovic, LO Mosnier - International journal of hematology, 2012 - Springer
Plasma protein C is a serine protease zymogen that is transformed into the active, trypsin-
like protease, activated protein C (APC), which can exert multiple activities. For its …